153 related articles for article (PubMed ID: 27714883)
1. Characteristics of C-terminal, β-amyloid peptide binding fragment of neuroprotective protease inhibitor, cystatin C.
Spodzieja M; Kalejta K; Kołodziejczyk AS; Maszota-Zieleniak M; Rodziewicz-Motowidło S; Żmudzińska W; Czaplewska P
J Mol Recognit; 2017 Feb; 30(2):. PubMed ID: 27714883
[TBL] [Abstract][Full Text] [Related]
2. Binding epitopes and interaction structure of the neuroprotective protease inhibitor cystatin C with beta-amyloid revealed by proteolytic excision mass spectrometry and molecular docking simulation.
Juszczyk P; Paraschiv G; Szymanska A; Kolodziejczyk AS; Rodziewicz-Motowidlo S; Grzonka Z; Przybylski M
J Med Chem; 2009 Apr; 52(8):2420-8. PubMed ID: 19317448
[TBL] [Abstract][Full Text] [Related]
3. Structural studies of the C-terminal 19-peptide of serum amyloid A and its Pro → Ala variants interacting with human cystatin C.
Maszota M; Karska N; Spodzieja M; Ciarkowski J; Kołodziejczyk AS; Rodziewicz-Motowidło S; Czaplewska P
J Mol Recognit; 2015 Jul; 28(7):413-26. PubMed ID: 25736604
[TBL] [Abstract][Full Text] [Related]
4. Interaction of serum amyloid A with human cystatin C--identification of binding sites.
Spodzieja M; Szymańska A; Kołodziejczyk A; Prądzińska M; Maszota M; Stefanowicz P; Szewczuk Z; Grubb A; Czaplewska P
J Mol Recognit; 2012 Oct; 25(10):513-24. PubMed ID: 22996594
[TBL] [Abstract][Full Text] [Related]
5. Interaction of serum amyloid A with human cystatin C--assessment of amino acid residues crucial for hCC-SAA formation (part II).
Spodzieja M; Rafalik M; Szymańska A; Kołodziejczyk AS; Czaplewska P
J Mol Recognit; 2013 Sep; 26(9):415-25. PubMed ID: 23836469
[TBL] [Abstract][Full Text] [Related]
6. A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.
Perlenfein TJ; Murphy RM
J Biol Chem; 2017 Dec; 292(51):21071-21082. PubMed ID: 29046353
[TBL] [Abstract][Full Text] [Related]
7. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation.
Sastre M; Calero M; Pawlik M; Mathews PM; Kumar A; Danilov V; Schmidt SD; Nixon RA; Frangione B; Levy E
Neurobiol Aging; 2004 Sep; 25(8):1033-43. PubMed ID: 15212828
[TBL] [Abstract][Full Text] [Related]
8. Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer's Disease.
Mocanu CS; Jureschi M; Drochioiu G
Molecules; 2020 Oct; 25(19):. PubMed ID: 33022965
[TBL] [Abstract][Full Text] [Related]
9. Exploring the 'aggregation-prone' core of human Cystatin C: A structural study.
Tsiolaki PL; Louros NN; Hamodrakas SJ; Iconomidou VA
J Struct Biol; 2015 Sep; 191(3):272-80. PubMed ID: 26235923
[TBL] [Abstract][Full Text] [Related]
10. The role of the Val57 amino-acid residue in the hinge loop of the human cystatin C. Conformational studies of the beta2-L1-beta3 segments of wild-type human cystatin C and its mutants.
Rodziewicz-Motowidło S; Iwaszkiewicz J; Sosnowska R; Czaplewska P; Sobolewski E; Szymańska A; Stachowiak K; Liwo A
Biopolymers; 2009 May; 91(5):373-83. PubMed ID: 19137579
[TBL] [Abstract][Full Text] [Related]
11. Epitope structure and binding affinity of single chain llama anti-β-amyloid antibodies revealed by proteolytic excision affinity-mass spectrometry.
Paraschiv G; Vincke C; Czaplewska P; Manea M; Muyldermans S; Przybylski M
J Mol Recognit; 2013 Jan; 26(1):1-9. PubMed ID: 23280612
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C in aging and in Alzheimer's disease.
Mathews PM; Levy E
Ageing Res Rev; 2016 Dec; 32():38-50. PubMed ID: 27333827
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and physicochemical studies of amyloidogenic hexapeptides derived from human cystatin C.
Iłowska E; Sawicka J; Szymańska A
J Pept Sci; 2018 Jun; 24(4-5):e3073. PubMed ID: 29573035
[TBL] [Abstract][Full Text] [Related]
14. Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques.
Dhanavade MJ; Sonawane KD
Amino Acids; 2014 Aug; 46(8):1853-66. PubMed ID: 24729013
[TBL] [Abstract][Full Text] [Related]
15. The identification of discontinuous epitope in the human cystatin C - Monoclonal antibody HCC3 complex.
Rafalik M; Spodzieja M; Kołodziejczyk AS; Rodziewicz-Motowidło S; Szymańska A; Grubb A; Czaplewska P
J Proteomics; 2019 Jan; 191():58-67. PubMed ID: 29684685
[TBL] [Abstract][Full Text] [Related]
16. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
[TBL] [Abstract][Full Text] [Related]
17. Zinc-induced heterodimer formation between metal-binding domains of intact and naturally modified amyloid-beta species: implication to amyloid seeding in Alzheimer's disease?
Mezentsev YV; Medvedev AE; Kechko OI; Makarov AA; Ivanov AS; Mantsyzov AB; Kozin SA
J Biomol Struct Dyn; 2016 Nov; 34(11):2317-26. PubMed ID: 26513486
[TBL] [Abstract][Full Text] [Related]
18. Human cystatin C induces the disaggregation process of selected amyloid beta peptides: a structural and kinetic view.
Żyła A; Martel A; Jurczak P; Moliński A; Szymańska A; Kozak M
Sci Rep; 2023 Nov; 13(1):20833. PubMed ID: 38012338
[TBL] [Abstract][Full Text] [Related]
19. The pentapeptide LQVVR plays a pivotal role in human cystatin C fibrillization.
Tsiolaki PL; Hamodrakas SJ; Iconomidou VA
FEBS Lett; 2015 Jan; 589(1):159-64. PubMed ID: 25479090
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling approach to explore the role of cathepsin B from Hordeum vulgare in the degradation of Aβ peptides.
Dhanavade MJ; Parulekar RS; Kamble SA; Sonawane KD
Mol Biosyst; 2016 Jan; 12(1):162-8. PubMed ID: 26568474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
